相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Generation of induced pluripotent stem cells (NIMHi004-A, NIMHi005-A and NIMHi006-A) from healthy individuals of Indian ethnicity with no mutation for Parkinson's disease related genes
Soham Jagtap et al.
STEM CELL RESEARCH (2022)
A monolayer hiPSC culture system for autophagy/mitophagy studies in human dopaminergic neurons
Petros Stathakos et al.
AUTOPHAGY (2021)
Therapeutic Potential of Vital Transcription Factors in Alzheimer's and Parkinson's Disease With Particular Emphasis on Transcription Factor EB Mediated Autophagy
Sachchida Nand Rai et al.
FRONTIERS IN NEUROSCIENCE (2021)
R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils
Ying Fan et al.
ACTA NEUROPATHOLOGICA (2021)
In vitro genome editing rescues parkinsonism phenotypes in induced pluripotent stem cells-derived dopaminergic neurons carrying LRRK2 p.G2019S mutation
Kuo-Hsuan Chang et al.
STEM CELL RESEARCH & THERAPY (2021)
Promising drug targets and associated therapeutic interventions in Parkinson's disease
Sachchida Nand Rai et al.
NEURAL REGENERATION RESEARCH (2021)
Estrogen receptors differentially regulate intracellular calcium handling in human nonasthmatic and asthmatic airway smooth muscle cells
Sangeeta Bhallamudi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2020)
Advancement in the modelling and therapeutics of Parkinson's disease
Sachchida Nand Rai et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2020)
Generation of induced pluripotent stem cells (NIMHi001-A) from a Parkinson's disease patient of East Indian ethnicity carrying LRRK2 I1371V
Indrani Datta et al.
STEM CELL RESEARCH (2020)
Evaluating In Vitro Neonatal Hypoxic-Ischemic Injury Using Neural Progenitors Derived from Human Embryonic Stem Cells
Sowmithra Sowmithra et al.
STEM CELLS AND DEVELOPMENT (2020)
Precision medicine in Parkinson's disease patients with LRRK2 and GBA risk variants - Let's get even more personal
Christian U. von Linstow et al.
TRANSLATIONAL NEURODEGENERATION (2020)
Mucuna pruriens in Parkinson's and in some other diseases: recent advancement and future prospective
Sachchida Nand Rai et al.
3 BIOTECH (2020)
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons
Kirill Zaslaysky et al.
NATURE NEUROSCIENCE (2019)
Role of the endolysosomal system in Parkinson's disease
D. J. Vidyadhara et al.
JOURNAL OF NEUROCHEMISTRY (2019)
The epilepsy-associated protein TBC1D24 is required for normal development, survival and vesicle trafficking in mammalian neurons
Mattea J. Finelli et al.
HUMAN MOLECULAR GENETICS (2019)
Impact of ethnicity on the natural history of Parkinson disease
Anna Sauerbier et al.
MEDICAL JOURNAL OF AUSTRALIA (2018)
Generation of 2 induced pluripotent stem cell lines derived from patients with Parkinson's disease carrying LRRK2 G2385R variant
Yu-Che Cheng et al.
STEM CELL RESEARCH (2018)
Cyclin-dependent kinase 5-mediated phosphorylation of chloride intracellular channel 4 promotes oxidative stress-induced neuronal death
Dong Guo et al.
CELL DEATH & DISEASE (2018)
Mutant TDP-43 does not impair mitochondrial bioenergetics in vitro and in vivo
Hibiki Kawamata et al.
MOLECULAR NEURODEGENERATION (2017)
In vitro generation of mature midbrain-type dopamine neurons by adjusting exogenous Nurr1 and Foxa2 expressions to their physiologic patterns
Taeho Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
Emerging biological roles of Cl- intracellular channel proteins
Elisabetta Argenzio et al.
JOURNAL OF CELL SCIENCE (2016)
Differential Neuronal Plasticity of Dental Pulp Stem Cells From Exfoliated Deciduous and Permanent Teeth Towards Dopaminergic Neurons
Debanjana Majumdar et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2016)
LRRK2 G2019S transgenic mice display increased susceptibility to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-mediated neurotoxicity
Senthilkumar S. Karuppagounder et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2016)
Mutations in LRRK2 impair NF-κB pathway in iPSC-derived neurons
Rakel Lopez de Maturana et al.
JOURNAL OF NEUROINFLAMMATION (2016)
Altered Development of Synapse Structure and Function in Striatum Caused by Parkinson's Disease-Linked LRRK2-G2019S Mutation
Bridget A. Matikainen-Ankney et al.
JOURNAL OF NEUROSCIENCE (2016)
Molecular identity of cardiac mitochondrial chloride intracellular channel proteins
Devasena Ponnalagu et al.
MITOCHONDRION (2016)
G2385R and I2020T Mutations Increase LRRK2 GTPase Activity
Dong Hwan Ho et al.
BIOMED RESEARCH INTERNATIONAL (2016)
The RAB39B p.G192R mutation causes X-linked dominant Parkinson's disease
Ignacio F. Mata et al.
MOLECULAR NEURODEGENERATION (2015)
Mutant LRRK2 enhances glutamatergic synapse activity and evokes excitotoxic dendrite degeneration
Edward D. Plowey et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
DNAJC13 mutations in Parkinson disease
Carles Vilarino-Gueell et al.
HUMAN MOLECULAR GENETICS (2014)
CLIC4 regulates cell adhesion and β1 integrin trafficking
Elisabetta Argenzio et al.
JOURNAL OF CELL SCIENCE (2014)
Midbrain Cues Dictate Differentiation of Human Dental Pulp Stem Cells Towards Functional Dopaminergic Neurons
Mohammad Kanafi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2014)
LRRK2 mutations cause mitochondrial DNA damage in iPSC-derived neural cells from Parkinson's disease patients: Reversal by gene correction
Laurie H. Sanders et al.
NEUROBIOLOGY OF DISEASE (2014)
Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice
Dayne A. Beccano-Kelly et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Transcription factors Foxa1 and Foxa2 are required for adult dopamine neurons maintenance
Andrii Domanskyi et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Disease duration and the integrity of the nigrostriatal system in Parkinson's disease
Jeffrey H. Kordower et al.
BRAIN (2013)
Directed differentiation of human embryonic stem cell-line HUES9 to dopaminergic neurons in a serum-free defined culture niche
Indrani Datta et al.
CELL BIOLOGY INTERNATIONAL (2013)
Foxa1 and Foxa2 Are Required for the Maintenance of Dopaminergic Properties in Ventral Midbrain Neurons at Late Embryonic Stages
Simon R. W. Stott et al.
JOURNAL OF NEUROSCIENCE (2013)
The Parkinson's Disease-Associated LRRK2 Mutation R1441G Inhibits Neuronal Differentiation of Neural Stem Cells
Lamia'a Bahnassawy et al.
STEM CELLS AND DEVELOPMENT (2013)
Evaluation of the role of LRRK2 gene in Parkinson's disease in an East Indian cohort
Tamal Sadhukhan et al.
DISEASE MARKERS (2012)
Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson's Disease
Oliver Cooper et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease
Alexander Zimprich et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
VPS35 Mutations in Parkinson Disease
Carles Vilarino-Gueell et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2011)
LRRK2 Mutant iPSC-Derived DA Neurons Demonstrate Increased Susceptibility to Oxidative Stress
Ha Nam Nguyen et al.
CELL STEM CELL (2011)
LRRK2 G2019S mutation does not contribute to Parkinson's disease in South India
Bejoy Vijayan et al.
NEUROLOGY INDIA (2011)
Coordinate Regulation of Neurite Outgrowth by LRRK2 and Its Interactor, Rab5
Hye Young Heo et al.
Experimental Neurobiology (2011)
14-3-3 binding to LRRK2 is disrupted by multiple Parkinson's disease-associated mutations and regulates cytoplasmic localization
R. Jeremy Nichols et al.
BIOCHEMICAL JOURNAL (2010)
Lrrk2 phosphorylates alpha synuclein at serine 129: Parkinson disease implications
Hong Qing et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Can cellular models revolutionize drug discovery in Parkinson's disease?
Birgitt Schuele et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2009)
Homo- and heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragment
Christian L. Klein et al.
JOURNAL OF NEUROCHEMISTRY (2009)
Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease
Wataru Satake et al.
NATURE GENETICS (2009)
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Javier Simon-Sanchez et al.
NATURE GENETICS (2009)
Mutant LRRK2R1441G BAC transgenic mice recapitulate cardinal features of Parkinson's disease
Yanping Li et al.
NATURE NEUROSCIENCE (2009)
Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease
Owen A. Ross et al.
ANNALS OF NEUROLOGY (2008)
LRRK2 R1628P increases risk of Parkinson's disease: replication evidence
E. K. Tan et al.
HUMAN GENETICS (2008)
Structure of the ROC domain from the Parkinson's disease-associated leucine-rich repeat kinase 2 reveals a dimeric GTPase
Junpeng Deng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Functional reconstitution of mammalian 'chloride intracellular channels' CLIC1, CLIC4 and CLIC5 reveals differential regulation by cytoskeletal actin
H. Singh et al.
FEBS JOURNAL (2007)
Increased expression of golli myelin basic proteins enhances calcium influx into oligodendroglial cells
Pablo M. Paez et al.
JOURNAL OF NEUROSCIENCE (2007)
Green fluorescent protein impairs actin-myosin interactions by binding to the actin-binding site of myosin
Onnik Agbulut et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Neuropathology of Parkinson's disease associated with the LRRK2 Ile1371Val mutation
Maria Teresa Giordana et al.
MOVEMENT DISORDERS (2007)
Biochemical and pathological characterization of Lrrk2
BI Giasson et al.
ANNALS OF NEUROLOGY (2006)
The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity
CJ Gloeckner et al.
HUMAN MOLECULAR GENETICS (2006)
Capsaicin stimulates the non-store-operated Ca2+ entry but inhibits the store-operated Ca2+ entry in neutrophils
JP Wang et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2005)
LRRK2 gene in Parkinson disease -: Mutation analysis and case control association study
C Paisán-Ruíz et al.
NEUROLOGY (2005)
Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells
YP Yan et al.
STEM CELLS (2005)
Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease
C Paisán-Ruíz et al.
NEURON (2004)
Mutations in LRRK2 cause autosomal-dominant Parkinsonism with pleomorphic pathology
A Zimprich et al.
NEURON (2004)
Hereditary early-onset Parkinson's disease caused by mutations in PINK1
EM Valente et al.
SCIENCE (2004)
Midbrain dopaminergic neurons:: control of their cell fate by the engrailed transcription factors
HH Simon et al.
CELL AND TISSUE RESEARCH (2004)
Neurosphere and neurosphere-forming cells: morphological and ultrastructural characterization
A Bez et al.
BRAIN RESEARCH (2003)
Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism
V Bonifati et al.
SCIENCE (2003)
Animal models of Parkinson's disease
R Betarbet et al.
BIOESSAYS (2002)
α-Synuclein is phosphorylated in synucleinopathy lesions
H Fujiwara et al.
NATURE CELL BIOLOGY (2002)
A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1
M Funayama et al.
ANNALS OF NEUROLOGY (2002)
Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells
SH Lee et al.
NATURE BIOTECHNOLOGY (2000)
分享论文
